Medicines

Tackling AMR and medicine shortages in the EU

How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.

Attracting major investors: GreenLight on the international stage

In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.

COVID-19: Maintaining quality control in testing times

With the onset of the COVID-19 pandemic, UKAS highlights the importance of maintaining quality control in testing times.

COVID-19: The time for mental healthcare reform is now

Jennifer Oroilidis and Marie Fallon-Kund, from Mental Health Europe, argue that in light of COVID-19, the time for mental healthcare reform is now.

The silence before the tsunami: COVID is devastating behind NHS virus frontlines

Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.

Japan and EU work on strategic partnership for COVID-19 pandemic

President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.

Turkey and COVID-19: Success, turmoil, insecurity and opportunity

Dr Ahmet Erdi Öztürk, expert on Turkish politics, discusses the ongoing realities of Turkey and COVID-19.

Existing drugs should be used to treat COVID-19 instead of vaccine

Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.

It should never have taken COVID-19 for us to value rapid testing

Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.

PMQ’s summary: The NHS, PPE acquisition and knife crime

On 29 April, First Secretary Dominic Raab discussed government plans in relation to crucial issues such as PPE acquisition and knife crime.

The science behind the Hong Kong COVID-19 strategy

Currently, the country has only experienced four deaths: What is the Hong Kong COVID-19 strategy and why is it working so well?

Will tech democratise access to quality healthcare?

Neil Ballinger, head of EMEA sales at EU Automation, explains how greater access to quality healthcare can come from medical data and AI.

Growing pains: Creating value in the maturing cannabis market

Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.

Economic and scientific experts discuss EU response to COVID-19

Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.

Researchers test drug that stops early stages of COVID-19

Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.

Cannabinoids in medicine part 4: Epilepsy

In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.

Malta’s stance on cannabis for medicinal and research purposes

Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders